Craig A. Rosen
#167,708
Most Influential Person Now
Craig A. Rosen's AcademicInfluence.com Rankings
Craig A. Rosenbiology Degrees
Biology
#13688
World Rank
#17243
Historical Rank
Genetics
#1537
World Rank
#1640
Historical Rank
Molecular Biology
#2335
World Rank
#2370
Historical Rank
Download Badge
Biology
Craig A. Rosen's Degrees
- PhD Genetics Stanford University
Why Is Craig A. Rosen Influential?
(Suggest an Edit or Addition)Craig A. Rosen's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer (1994) (1620)
- Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. (1987) (828)
- Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity (1986) (759)
- Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells. (1984) (720)
- The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat (1985) (682)
- A second post-transcriptional trans-activator gene required for HTLV-III replication (1986) (582)
- Molecular Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinase 4* (1996) (581)
- The trans-activator gene of the human T cell lymphotropic virus type III is required for replication (1986) (573)
- Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. (1985) (556)
- Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III. (1985) (477)
- Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. (1985) (443)
- Structural and functional characterization of human immunodeficiency virus tat protein (1989) (438)
- Use of a Whole Genome Approach To Identify Vaccine Molecules Affording Protection against Streptococcus pneumoniae Infection (2001) (361)
- A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. (1990) (355)
- Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. (1988) (332)
- A transcriptional activator protein encoded by the x-lor region of the human T-cell leukemia virus. (1985) (318)
- Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus (1987) (296)
- Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine. (1987) (271)
- Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III (1986) (264)
- Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to function (1990) (264)
- Defective mitosis due to a mutation in the gene for a fission yeast 26S protease subunit (1993) (229)
- Effects of mutations within the 3' orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity (1986) (220)
- Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. (1986) (219)
- Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1. (1987) (219)
- A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator. (1990) (219)
- Human stanniocalcin: a possible hormonal regulator of mineral metabolism. (1996) (216)
- Chip, a widely expressed chromosomal protein required for segmentation and activity of a remote wing margin enhancer in Drosophila. (1997) (215)
- Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids. (1990) (198)
- A rapid method for the construction of synthetic genes using the polymerase chain reaction. (1990) (187)
- Secondary structure is the major determinant for interaction of HIV rev protein with RNA. (1990) (181)
- HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. (1992) (173)
- Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression (1991) (164)
- Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA. (1990) (161)
- Mutational analysis of the 5′ non‐coding region of human immunodeficiency virus type 1: effects of secondary structure on translation. (1988) (158)
- Subcellular localization of the human immunodeficiency virus trans-acting art gene product (1988) (147)
- Human Stanniocalcin Inhibits Renal Phosphate Excretion in the Rat (1997) (141)
- Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequences (1985) (127)
- Location of cis-acting regulatory sequences in the human T-cell leukemia virus type I long terminal repeat. (1985) (124)
- Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence (1990) (124)
- Bioassay for trans-activation using purified human immunodeficiency virus tat-encoded protein: trans-activation requires mRNA synthesis. (1989) (121)
- Trans-activator gene of HTLV-II induces IL-2 receptor and IL-2 cellular gene expression. (1986) (120)
- Reed-Sternberg cell genome expression supports a B-cell lineage. (1999) (118)
- Subcellular localization of the product of the long open reading frame of human T-cell leukemia virus type I. (1985) (104)
- Structural and functional characterization of the human immunodeficiency virus rev protein. (1989) (103)
- The art gene product of human immunodeficiency virus is required for replication (1988) (102)
- Identification of a Naturally Occurring Transforming Variant of the p65 Subunit of NF-KB (1992) (100)
- Tat and Rev: positive regulators of HIV gene expression. (1990) (100)
- Trans activation of the bovine leukemia virus long terminal repeat in BLV-infected cells. (1985) (93)
- In vivo activation of human immunodeficiency virus type 1 long terminal repeat by UV type A (UV-A) light plus psoralen and UV-B light in the skin of transgenic mice (1991) (92)
- Chip interacts with diverse homeodomain proteins and potentiates bicoid activity in vivo. (2000) (90)
- Construction of recombinant murine retroviruses that express the human T-cell leukemia virus type II and human T-cell lymphotropic virus type III trans activator genes (1986) (87)
- Genes regulating the remote wing margin enhancer in the Drosophila cut locus. (1996) (86)
- Contribution of the TATA motif to Tat-mediated transcriptional activation of human immunodeficiency virus gene expression (1992) (79)
- Regulation of HIV gene expression by RNA-protein interactions. (1991) (68)
- Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rev proteins in transfected cells. (1991) (66)
- The number of positively charged amino acids in the basic domain of Tat is critical for trans-activation and complex formation with TAR RNA. (1991) (66)
- The human immunodeficiency virus rev protein is a nuclear phosphoprotein. (1989) (66)
- Multiple sequence elements are required for regulation of human T-cell leukemia virus gene expression. (1987) (65)
- Function of the human immunodeficiency virus types 1 and 2 Rev proteins is dependent on their ability to interact with a structured region present in env gene mRNA (1990) (65)
- The HIV-1 Rev protein: a model system for coupled RNA transport and translation. (1991) (64)
- The DNA-binding and enhancer-blocking domains of the Drosophila suppressor of Hairy-wing protein (1996) (63)
- Identification of a region within the human immunodeficiency virus type 1 long terminal repeat that is essential for transactivation by the hepatitis B virus gene X (1989) (62)
- Human growth hormone (1972) (51)
- Interaction of cellular factors with intragenic cis-acting repressive sequences within the HIV genome. (1992) (46)
- IKB interacts with the nuclear localization sequences of the subunits of NF-KB: a mechanism for cytoplasmic retention (2007) (44)
- Functional significance of phosphorylation to the human immunodeficiency virus Rev protein (1989) (41)
- Disparate effects of two herpesviruses immediate-early gene trans-activators on the HIV-1 LTR (1989) (40)
- GRS, a novel member of the Bcl-2 gene family, is highly expressed in multiple cancer cell lines and in normal leukocytes (1997) (39)
- trans-Activation of the human T-cell leukemia virus long terminal repeat correlates with expression of the x-lor protein (1985) (37)
- Activation of enhancer sequences in type II human T-cell leukemia virus and bovine leukemia virus long terminal repeats by virus-associated trans-acting regulatory factors (1986) (35)
- Mutational analysis of the HIV-1 Rev protein and its target sequence, the Rev responsive element. (1991) (34)
- The 3′ region of bovine leukemia virus genome encodes a trans‐activator protein. (1986) (33)
- Identification of a protein encoded by the trans activator gene tatIII of human T-cell lymphotropic retrovirus type III (1986) (33)
- Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120. (1994) (31)
- Selection of Optimal KB/Rel DNA-Binding Motifs: Interaction of Both Subunits of NF-iB with DNA Is Required for Transcriptional Activation (2003) (31)
- HIV regulatory proteins: potential targets for therapeutic intervention. (1992) (27)
- Cloning and characterization of a novel human DNase. (1997) (26)
- Use of polymerase chain reaction for the rapid construction of synthetic genes. (1993) (25)
- Translational control of vesicular stomatitis virus protein synthesis: isolation of an mRNA-sequestering particle (1982) (25)
- Construction of a replication-competent murine retrovirus vector expressing the human immunodeficiency virus type 1 tat transactivator protein (1991) (24)
- Purification of biologically active human immunodeficiency virus rev protein from Escherichia coli. (1989) (24)
- Structural and functional analysis of the human immunodeficiency virus type 2 Rev protein (1991) (21)
- HIV ENVELOPE-CD4 INTERACTION NOT INHIBITED BY SYNTHETIC OCTAPEPTIDES (1987) (20)
- Expression of the art gene protein of human T-lymphotropic virus type III (HTLV-III/LAV) in bacteria (1987) (20)
- Transgenic dissection of HIV genes involved in lymphoid depletion. (1997) (18)
- Structure and expression of wild-type and suppressible alleles of the Drosophila purple gene. (1996) (18)
- HIV-1 LTR activation model: evaluation of various agents in skin of transgenic mice. (1992) (16)
- A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. (1990) (16)
- A proline-rich region in the Zeste protein essential for transvection and white repression by Zeste. (1998) (15)
- A nuclear factor is required for transactivation of HTLV-I gene expression. (1988) (12)
- Transcription directed by the HIV long terminal repeat in vitro. (1987) (12)
- Tat and Rev: positive regulators of HIV gene expression. (1990) (11)
- Inhibition of protein synthesis in vesicular stomatitis virus infected Chinese hamster ovary cells: role of virus mRNA-ribonucleoprotein particle. (1984) (10)
- Identification of a new protein present in vesicular stomatitis virus-infected Chinese hamster ovary cells as a degradation product of viral M protein. (1983) (8)
- Tat and Rev: positive modulators of human immunodeficiency virus gene expression. (1991) (7)
- I-Rel: a novel rei-related protein that inhibits NF-KB transcriptional activity (2007) (5)
- Location ofcis-acting regulatory sequences inthehumanT-cell leukemia virus typeIlongterminal repeat (1985) (5)
- Replication and pathogenesis of the human T-cell leukemia/lymphotropic retroviruses. (1987) (4)
- Trans-activator gene of HTLV-II: interpretation. (1987) (4)
- The lor gene and pathogenesis of HTLV-I, -II, and -III. (1985) (3)
- Expression of the x-lor gene of human T-cell leukemia virus I in Escherichia coli (1985) (3)
- Large scale sequencing of ESTs from human osteoclast cDNA library: “electronic northern blot” (1995) (2)
- Control of gene expression and the replication and pathogenesis of retroviruses. (1986) (2)
- Editorial overview: genetics, genomics and drug discovery (1994) (1)
- Structure and function of human leukemia and AIDS viruses. (1984) (1)
- In vivo regulation of HIV-1 long terminal repeat by UV light and various skin applicants in transgenic mice (1991) (1)
- The development of genomics-derived pharmaceuticals. (2001) (1)
- Genome-wide gene expression of the rare, malignant Reed-Sternberg cell of Hodgkin lymphoma (1999) (1)
- Disparate effects of two herpesvirus [corrected] immediate-early gene trans-activators on the HIV-1 LTR. (1989) (1)
- Construction of Synthetic Genes by Polymerase Chain Reaction (2000) (1)
- 86 proteines secretees humaines (1998) (0)
- 33 proteines humaines secretees (1999) (0)
- Transactivator Genes of HTLV-I, II, and III (1986) (0)
- 71 proteines humaines secretees (1998) (0)
- Cis-acting repression and cis-acting antirepression sequences, vector, its preparation and use thereof (1988) (0)
- RNA — Protein Interactions Required for Rev Mediated Regulation of HIV Gene Expression (1991) (0)
- Protein capable of being bound to antigen and its production (1993) (0)
- Human alpha endokin (1996) (0)
- 101 proteines humaines secretees (1998) (0)
- Anticorps diriges contre le recepteur c3a (2003) (0)
- Identification ofa Regionwithin theHumanImmunodeficiency VirusType1LongTerminal RepeatThatIsEssential for Transactivation bytheHepatitis B VirusGeneX (1989) (0)
- 48 proteines humaines secretees (2000) (0)
- 4981790 Stable tatIII cell lines, tatIII gene products, and assay methods (1991) (0)
- Fusion proteins albumin and GCSF (2002) (0)
- Albumin and interferon beta fusion proteins (2002) (0)
- Anticorps qui se lient specifiquement a reg iv (2003) (0)
- Abstract 2167: An Albumin-BNP Fusion Protein Increases Natriuresis Without Compromising Renal or Left Ventricular Function in Severe Congestive Heart Failure (2006) (0)
- 125 proteines secretees humaines (1998) (0)
- Recepteur de neuropeptides humain (1995) (0)
- Methodes de traitement et de prevention de la restenose (2000) (0)
- Cis-effect repression sequences, cis-effect anti-repression sequences, vectors, methods for the preparation and application. (1988) (0)
- 22 proteines humaines secretees (2000) (0)
- Chapter 18. Function of Human Retrovirus Regulatory Proteins (1991) (0)
- 53 proteines secretees humaines (1998) (0)
- Recepteur humain du neuropeptide (2000) (0)
- AIDS 1995. Virology: overview. (1995) (0)
- 70 proteines secretees humaines (1998) (0)
- The extracellular matrix protein 1 inhibits mineralization of cultured metatarsals (1998) (0)
- The common cytokine receptor gamma-chain-like (1999) (0)
- Receiver 5 containing a death domain. (1998) (0)
- 94 proteines humaines secretees (1999) (0)
- Function oftheHumanImmunodeficiency VirusTypes1 and2Rev Proteins IsDependent on TheirAbility ToInteract witha Structured RegionPresent inenv GenemRNA (1990) (0)
- "Death domain" -containing receptor 4 (DR4), a member of the TNF receptor super family, which binds to TRAIL (APO-2L) (1998) (0)
- 48 proteines secretees humaines (2000) (0)
- 207 proteines secretees humaines (1998) (0)
- Apoptosis proteases-3 and 4, similar to the interleukin-1beta converting enzyme for (1995) (0)
- 123 proteines humaines secretees (1998) (0)
- Transcription factors with trans activity. (1985) (0)
- Human alpha-endokine (1996) (0)
- 17 proteines humaines secretees (2001) (0)
- Growth factor vascular endothelial 2. (1994) (0)
- 207 proteines humaines secretees (1998) (0)
- Humanized antibodies to tl1a (2008) (0)
- 11 Patent Number : 5 , 985 , 614 ( 45 ) Date of Patent : Nov . 16 , 1999 54 POLYNUCLEOTIDES ENCODING INTERLEUKIN-19 75 Inventors : (2017) (0)
- A Genomics-Based Approach to Regenerative Medicine (2002) (0)
- Endokine human alpha. (1996) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Craig A. Rosen?
Craig A. Rosen is affiliated with the following schools:
